BackCharles River Laboratories International Overview
Charles River Laboratories International Inc.

Charles River Laboratories International Return on Equity

Charles River Laboratories International (CRL) has a ROE of -8.4%, below the Healthcare sector average of 20.77%.

Get informed when a big investor buys or sells

+ Follow

ROE

-8.40%

Return on Equity

-8.40%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Charles River Laboratories International (CRL) FAQ

As of the most recent data, CRL shows a ROE of -8.4%. That is below the Healthcare sector average of 20.77%. Scroll down for historical charts and peer comparison views.

The Healthcare sector average ROE is about 20.77%. Charles River Laboratories International is at -8.4%, which is lower that average. That is roughly 140.4% below the sector mean. Use the comparison chart on this page to see how CRL stacks up against individual peers as well.

Check the historical chart to see whether CRL's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Charles River Laboratories International with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Charles River Laboratories International's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently -8.4%) with ownership activity and broader fundamentals.

The Healthcare average ROE is about 20.77%, while CRL is at -8.4%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.